# Clinical Response and Toxicity of Hypo-fractionated Chemoradiotherapy in Cervix Cancer

> **NCT04831437** · PHASE2 · RECRUITING · sponsor: **Tehran University of Medical Sciences** · enrollment: 60 (estimated)

## Conditions studied

- Cervix Uteri Cancer

## Interventions

- **RADIATION:** Hypofractionated EBRT
- **RADIATION:** Standard EBRT

## Key facts

- **NCT ID:** NCT04831437
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-01
- **Primary completion:** 2023-03
- **Final completion:** 2028-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04831437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04831437, "Clinical Response and Toxicity of Hypo-fractionated Chemoradiotherapy in Cervix Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04831437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*